nodes	percent_of_prediction	percent_of_DWPC	metapath
Cyproheptadine—HTR2A—phrenic nerve—peripheral nervous system neoplasm	0.0313	0.199	CbGeAlD
Cyproheptadine—HTR6—ganglion—peripheral nervous system neoplasm	0.0143	0.0903	CbGeAlD
Cyproheptadine—HTR2A—trigeminal nerve—peripheral nervous system neoplasm	0.0115	0.0726	CbGeAlD
Cyproheptadine—HTR2A—vagus nerve—peripheral nervous system neoplasm	0.0107	0.0679	CbGeAlD
Cyproheptadine—HTR2C—ganglion—peripheral nervous system neoplasm	0.00824	0.0522	CbGeAlD
Cyproheptadine—HTR2A—cranial nerve—peripheral nervous system neoplasm	0.00816	0.0517	CbGeAlD
Cyproheptadine—HTR2A—pons—peripheral nervous system neoplasm	0.00807	0.0511	CbGeAlD
Cyproheptadine—SLC6A2—nerve—peripheral nervous system neoplasm	0.00696	0.0441	CbGeAlD
Cyproheptadine—HTR1A—ganglion—peripheral nervous system neoplasm	0.00693	0.0439	CbGeAlD
Cyproheptadine—SLC6A2—ganglion—peripheral nervous system neoplasm	0.00688	0.0436	CbGeAlD
Cyproheptadine—Amitriptyline—NTRK2—peripheral nervous system neoplasm	0.00654	0.44	CrCbGaD
Cyproheptadine—DRD2—nerve—peripheral nervous system neoplasm	0.00634	0.0402	CbGeAlD
Cyproheptadine—DRD2—ganglion—peripheral nervous system neoplasm	0.00627	0.0397	CbGeAlD
Cyproheptadine—HTR2A—nerve—peripheral nervous system neoplasm	0.00418	0.0265	CbGeAlD
Cyproheptadine—HTR2A—ganglion—peripheral nervous system neoplasm	0.00413	0.0262	CbGeAlD
Cyproheptadine—Amitriptyline—NTRK1—peripheral nervous system neoplasm	0.00404	0.272	CrCbGaD
Cyproheptadine—CHRM1—parotid gland—peripheral nervous system neoplasm	0.0036	0.0228	CbGeAlD
Cyproheptadine—HTR2C—brainstem—peripheral nervous system neoplasm	0.00358	0.0227	CbGeAlD
Cyproheptadine—HTR1A—brainstem—peripheral nervous system neoplasm	0.00301	0.0191	CbGeAlD
Cyproheptadine—SLC6A2—brainstem—peripheral nervous system neoplasm	0.00299	0.0189	CbGeAlD
Cyproheptadine—DRD2—brainstem—peripheral nervous system neoplasm	0.00272	0.0173	CbGeAlD
Cyproheptadine—HRH1—trigeminal ganglion—peripheral nervous system neoplasm	0.00243	0.0154	CbGeAlD
Cyproheptadine—Protriptyline—ABCB1—peripheral nervous system neoplasm	0.00213	0.143	CrCbGaD
Cyproheptadine—Fatigue—Isotretinoin—peripheral nervous system neoplasm	0.00184	0.0025	CcSEcCtD
Cyproheptadine—Constipation—Topotecan—peripheral nervous system neoplasm	0.00184	0.0025	CcSEcCtD
Cyproheptadine—Decreased appetite—Melphalan—peripheral nervous system neoplasm	0.00183	0.00249	CcSEcCtD
Cyproheptadine—Constipation—Tretinoin—peripheral nervous system neoplasm	0.00183	0.00248	CcSEcCtD
Cyproheptadine—Constipation—Isotretinoin—peripheral nervous system neoplasm	0.00183	0.00248	CcSEcCtD
Cyproheptadine—Agitation—Alitretinoin—peripheral nervous system neoplasm	0.00182	0.00247	CcSEcCtD
Cyproheptadine—Fatigue—Melphalan—peripheral nervous system neoplasm	0.00182	0.00247	CcSEcCtD
Cyproheptadine—Tinnitus—Cisplatin—peripheral nervous system neoplasm	0.00181	0.00246	CcSEcCtD
Cyproheptadine—HTR2A—brainstem—peripheral nervous system neoplasm	0.0018	0.0114	CbGeAlD
Cyproheptadine—Syncope—Alitretinoin—peripheral nervous system neoplasm	0.00178	0.00241	CcSEcCtD
Cyproheptadine—Feeling abnormal—Topotecan—peripheral nervous system neoplasm	0.00177	0.00241	CcSEcCtD
Cyproheptadine—Feeling abnormal—Isotretinoin—peripheral nervous system neoplasm	0.00176	0.00239	CcSEcCtD
Cyproheptadine—Feeling abnormal—Tretinoin—peripheral nervous system neoplasm	0.00176	0.00239	CcSEcCtD
Cyproheptadine—Agitation—Vincristine—peripheral nervous system neoplasm	0.00176	0.00238	CcSEcCtD
Cyproheptadine—Palpitations—Alitretinoin—peripheral nervous system neoplasm	0.00175	0.00238	CcSEcCtD
Cyproheptadine—Oedema—Dactinomycin—peripheral nervous system neoplasm	0.00175	0.00237	CcSEcCtD
Cyproheptadine—Loss of consciousness—Alitretinoin—peripheral nervous system neoplasm	0.00174	0.00237	CcSEcCtD
Cyproheptadine—Convulsion—Alitretinoin—peripheral nervous system neoplasm	0.00172	0.00233	CcSEcCtD
Cyproheptadine—Vertigo—Vincristine—peripheral nervous system neoplasm	0.00172	0.00233	CcSEcCtD
Cyproheptadine—Leukopenia—Vincristine—peripheral nervous system neoplasm	0.00171	0.00232	CcSEcCtD
Cyproheptadine—Urticaria—Topotecan—peripheral nervous system neoplasm	0.00171	0.00232	CcSEcCtD
Cyproheptadine—Thrombocytopenia—Dactinomycin—peripheral nervous system neoplasm	0.00171	0.00232	CcSEcCtD
Cyproheptadine—Urticaria—Tretinoin—peripheral nervous system neoplasm	0.0017	0.0023	CcSEcCtD
Cyproheptadine—Urticaria—Isotretinoin—peripheral nervous system neoplasm	0.0017	0.0023	CcSEcCtD
Cyproheptadine—Urticaria—Melphalan—peripheral nervous system neoplasm	0.00168	0.00227	CcSEcCtD
Cyproheptadine—Anorexia—Dactinomycin—peripheral nervous system neoplasm	0.00166	0.00226	CcSEcCtD
Cyproheptadine—Convulsion—Vincristine—peripheral nervous system neoplasm	0.00166	0.00225	CcSEcCtD
Cyproheptadine—Photosensitivity—Epirubicin—peripheral nervous system neoplasm	0.00164	0.00223	CcSEcCtD
Cyproheptadine—Confusional state—Alitretinoin—peripheral nervous system neoplasm	0.00163	0.00222	CcSEcCtD
Cyproheptadine—Oedema—Alitretinoin—peripheral nervous system neoplasm	0.00162	0.0022	CcSEcCtD
Cyproheptadine—Hepatic failure—Epirubicin—peripheral nervous system neoplasm	0.0016	0.00218	CcSEcCtD
Cyproheptadine—Chills—Etoposide—peripheral nervous system neoplasm	0.0016	0.00217	CcSEcCtD
Cyproheptadine—Vision blurred—Cisplatin—peripheral nervous system neoplasm	0.00159	0.00216	CcSEcCtD
Cyproheptadine—Shock—Alitretinoin—peripheral nervous system neoplasm	0.00159	0.00216	CcSEcCtD
Cyproheptadine—Thrombocytopenia—Alitretinoin—peripheral nervous system neoplasm	0.00159	0.00215	CcSEcCtD
Cyproheptadine—Tremor—Cisplatin—peripheral nervous system neoplasm	0.00158	0.00215	CcSEcCtD
Cyproheptadine—Tachycardia—Alitretinoin—peripheral nervous system neoplasm	0.00158	0.00214	CcSEcCtD
Cyproheptadine—Hyperhidrosis—Alitretinoin—peripheral nervous system neoplasm	0.00157	0.00212	CcSEcCtD
Cyproheptadine—Oedema—Vincristine—peripheral nervous system neoplasm	0.00156	0.00212	CcSEcCtD
Cyproheptadine—Asthenia—Topotecan—peripheral nervous system neoplasm	0.00155	0.0021	CcSEcCtD
Cyproheptadine—Anorexia—Alitretinoin—peripheral nervous system neoplasm	0.00154	0.00209	CcSEcCtD
Cyproheptadine—Increased appetite—Epirubicin—peripheral nervous system neoplasm	0.00153	0.00208	CcSEcCtD
Cyproheptadine—Asthenia—Isotretinoin—peripheral nervous system neoplasm	0.00153	0.00208	CcSEcCtD
Cyproheptadine—Asthenia—Tretinoin—peripheral nervous system neoplasm	0.00153	0.00208	CcSEcCtD
Cyproheptadine—Thrombocytopenia—Vincristine—peripheral nervous system neoplasm	0.00153	0.00207	CcSEcCtD
Cyproheptadine—Photosensitivity—Doxorubicin—peripheral nervous system neoplasm	0.00152	0.00206	CcSEcCtD
Cyproheptadine—Decreased appetite—Dactinomycin—peripheral nervous system neoplasm	0.00152	0.00206	CcSEcCtD
Cyproheptadine—Leukopenia—Cisplatin—peripheral nervous system neoplasm	0.00151	0.00205	CcSEcCtD
Cyproheptadine—Asthenia—Melphalan—peripheral nervous system neoplasm	0.00151	0.00205	CcSEcCtD
Cyproheptadine—Hypotension—Alitretinoin—peripheral nervous system neoplasm	0.00151	0.00205	CcSEcCtD
Cyproheptadine—Hyperhidrosis—Vincristine—peripheral nervous system neoplasm	0.00151	0.00205	CcSEcCtD
Cyproheptadine—Fatigue—Dactinomycin—peripheral nervous system neoplasm	0.00151	0.00204	CcSEcCtD
Cyproheptadine—Anorexia—Vincristine—peripheral nervous system neoplasm	0.00149	0.00202	CcSEcCtD
Cyproheptadine—HTR1A—cerebellum—peripheral nervous system neoplasm	0.00149	0.00942	CbGeAlD
Cyproheptadine—Hepatic failure—Doxorubicin—peripheral nervous system neoplasm	0.00148	0.00201	CcSEcCtD
Cyproheptadine—Diarrhoea—Topotecan—peripheral nervous system neoplasm	0.00147	0.002	CcSEcCtD
Cyproheptadine—Convulsion—Cisplatin—peripheral nervous system neoplasm	0.00146	0.00199	CcSEcCtD
Cyproheptadine—Insomnia—Alitretinoin—peripheral nervous system neoplasm	0.00146	0.00199	CcSEcCtD
Cyproheptadine—Diarrhoea—Tretinoin—peripheral nervous system neoplasm	0.00146	0.00198	CcSEcCtD
Cyproheptadine—Diarrhoea—Isotretinoin—peripheral nervous system neoplasm	0.00146	0.00198	CcSEcCtD
Cyproheptadine—Hypotension—Vincristine—peripheral nervous system neoplasm	0.00146	0.00198	CcSEcCtD
Cyproheptadine—Paraesthesia—Alitretinoin—peripheral nervous system neoplasm	0.00145	0.00197	CcSEcCtD
Cyproheptadine—Diarrhoea—Melphalan—peripheral nervous system neoplasm	0.00144	0.00196	CcSEcCtD
Cyproheptadine—Diplopia—Epirubicin—peripheral nervous system neoplasm	0.00144	0.00196	CcSEcCtD
Cyproheptadine—Somnolence—Alitretinoin—peripheral nervous system neoplasm	0.00144	0.00195	CcSEcCtD
Cyproheptadine—Feeling abnormal—Dactinomycin—peripheral nervous system neoplasm	0.00144	0.00195	CcSEcCtD
Cyproheptadine—Dyspepsia—Alitretinoin—peripheral nervous system neoplasm	0.00143	0.00193	CcSEcCtD
Cyproheptadine—Dizziness—Topotecan—peripheral nervous system neoplasm	0.00142	0.00193	CcSEcCtD
Cyproheptadine—Increased appetite—Doxorubicin—peripheral nervous system neoplasm	0.00142	0.00193	CcSEcCtD
Cyproheptadine—Dizziness—Tretinoin—peripheral nervous system neoplasm	0.00141	0.00192	CcSEcCtD
Cyproheptadine—Dizziness—Isotretinoin—peripheral nervous system neoplasm	0.00141	0.00192	CcSEcCtD
Cyproheptadine—Insomnia—Vincristine—peripheral nervous system neoplasm	0.00141	0.00191	CcSEcCtD
Cyproheptadine—Decreased appetite—Alitretinoin—peripheral nervous system neoplasm	0.00141	0.00191	CcSEcCtD
Cyproheptadine—Paraesthesia—Vincristine—peripheral nervous system neoplasm	0.0014	0.0019	CcSEcCtD
Cyproheptadine—Fatigue—Alitretinoin—peripheral nervous system neoplasm	0.0014	0.00189	CcSEcCtD
Cyproheptadine—Vertigo—Etoposide—peripheral nervous system neoplasm	0.00139	0.00189	CcSEcCtD
Cyproheptadine—Leukopenia—Etoposide—peripheral nervous system neoplasm	0.00139	0.00188	CcSEcCtD
Cyproheptadine—Constipation—Alitretinoin—peripheral nervous system neoplasm	0.00138	0.00188	CcSEcCtD
Cyproheptadine—Oedema—Cisplatin—peripheral nervous system neoplasm	0.00138	0.00187	CcSEcCtD
Cyproheptadine—Vomiting—Topotecan—peripheral nervous system neoplasm	0.00137	0.00186	CcSEcCtD
Cyproheptadine—Loss of consciousness—Etoposide—peripheral nervous system neoplasm	0.00136	0.00185	CcSEcCtD
Cyproheptadine—Vomiting—Tretinoin—peripheral nervous system neoplasm	0.00136	0.00184	CcSEcCtD
Cyproheptadine—Vomiting—Isotretinoin—peripheral nervous system neoplasm	0.00136	0.00184	CcSEcCtD
Cyproheptadine—Rash—Topotecan—peripheral nervous system neoplasm	0.00136	0.00184	CcSEcCtD
Cyproheptadine—Dermatitis—Topotecan—peripheral nervous system neoplasm	0.00136	0.00184	CcSEcCtD
Cyproheptadine—Decreased appetite—Vincristine—peripheral nervous system neoplasm	0.00136	0.00184	CcSEcCtD
Cyproheptadine—Thrombocytopenia—Cisplatin—peripheral nervous system neoplasm	0.00135	0.00183	CcSEcCtD
Cyproheptadine—Headache—Topotecan—peripheral nervous system neoplasm	0.00135	0.00183	CcSEcCtD
Cyproheptadine—Rash—Tretinoin—peripheral nervous system neoplasm	0.00135	0.00183	CcSEcCtD
Cyproheptadine—Rash—Isotretinoin—peripheral nervous system neoplasm	0.00135	0.00183	CcSEcCtD
Cyproheptadine—Tachycardia—Cisplatin—peripheral nervous system neoplasm	0.00135	0.00183	CcSEcCtD
Cyproheptadine—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.00135	0.00183	CcSEcCtD
Cyproheptadine—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.00135	0.00183	CcSEcCtD
Cyproheptadine—Fatigue—Vincristine—peripheral nervous system neoplasm	0.00135	0.00183	CcSEcCtD
Cyproheptadine—DRD2—cerebellum—peripheral nervous system neoplasm	0.00134	0.00851	CbGeAlD
Cyproheptadine—Convulsion—Etoposide—peripheral nervous system neoplasm	0.00134	0.00182	CcSEcCtD
Cyproheptadine—Vomiting—Melphalan—peripheral nervous system neoplasm	0.00134	0.00182	CcSEcCtD
Cyproheptadine—Headache—Tretinoin—peripheral nervous system neoplasm	0.00134	0.00182	CcSEcCtD
Cyproheptadine—Headache—Isotretinoin—peripheral nervous system neoplasm	0.00134	0.00182	CcSEcCtD
Cyproheptadine—Feeling abnormal—Alitretinoin—peripheral nervous system neoplasm	0.00133	0.00181	CcSEcCtD
Cyproheptadine—Constipation—Vincristine—peripheral nervous system neoplasm	0.00133	0.00181	CcSEcCtD
Cyproheptadine—Diplopia—Doxorubicin—peripheral nervous system neoplasm	0.00133	0.00181	CcSEcCtD
Cyproheptadine—Hyperhidrosis—Cisplatin—peripheral nervous system neoplasm	0.00133	0.00181	CcSEcCtD
Cyproheptadine—Rash—Melphalan—peripheral nervous system neoplasm	0.00133	0.0018	CcSEcCtD
Cyproheptadine—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.00133	0.0018	CcSEcCtD
Cyproheptadine—Anorexia—Cisplatin—peripheral nervous system neoplasm	0.00132	0.00178	CcSEcCtD
Cyproheptadine—Hypotension—Cisplatin—peripheral nervous system neoplasm	0.00129	0.00175	CcSEcCtD
Cyproheptadine—Urticaria—Alitretinoin—peripheral nervous system neoplasm	0.00129	0.00175	CcSEcCtD
Cyproheptadine—Nausea—Topotecan—peripheral nervous system neoplasm	0.00128	0.00174	CcSEcCtD
Cyproheptadine—Confusional state—Etoposide—peripheral nervous system neoplasm	0.00127	0.00173	CcSEcCtD
Cyproheptadine—Nausea—Tretinoin—peripheral nervous system neoplasm	0.00127	0.00172	CcSEcCtD
Cyproheptadine—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.00127	0.00172	CcSEcCtD
Cyproheptadine—Asthenia—Dactinomycin—peripheral nervous system neoplasm	0.00125	0.0017	CcSEcCtD
Cyproheptadine—Nausea—Melphalan—peripheral nervous system neoplasm	0.00125	0.0017	CcSEcCtD
Cyproheptadine—Paraesthesia—Cisplatin—peripheral nervous system neoplasm	0.00124	0.00168	CcSEcCtD
Cyproheptadine—Thrombocytopenia—Etoposide—peripheral nervous system neoplasm	0.00124	0.00168	CcSEcCtD
Cyproheptadine—Tachycardia—Etoposide—peripheral nervous system neoplasm	0.00123	0.00167	CcSEcCtD
Cyproheptadine—Hyperhidrosis—Etoposide—peripheral nervous system neoplasm	0.00122	0.00166	CcSEcCtD
Cyproheptadine—Anorexia—Etoposide—peripheral nervous system neoplasm	0.0012	0.00163	CcSEcCtD
Cyproheptadine—Decreased appetite—Cisplatin—peripheral nervous system neoplasm	0.0012	0.00163	CcSEcCtD
Cyproheptadine—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.00119	0.00162	CcSEcCtD
Cyproheptadine—Hypotension—Etoposide—peripheral nervous system neoplasm	0.00118	0.0016	CcSEcCtD
Cyproheptadine—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.00116	0.00158	CcSEcCtD
Cyproheptadine—Pollakiuria—Epirubicin—peripheral nervous system neoplasm	0.00115	0.00156	CcSEcCtD
Cyproheptadine—Photosensitivity reaction—Epirubicin—peripheral nervous system neoplasm	0.00114	0.00154	CcSEcCtD
Cyproheptadine—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	0.00114	0.00154	CcSEcCtD
Cyproheptadine—Paraesthesia—Etoposide—peripheral nervous system neoplasm	0.00114	0.00154	CcSEcCtD
Cyproheptadine—Weight increased—Epirubicin—peripheral nervous system neoplasm	0.00113	0.00154	CcSEcCtD
Cyproheptadine—Somnolence—Etoposide—peripheral nervous system neoplasm	0.00112	0.00152	CcSEcCtD
Cyproheptadine—Asthenia—Vincristine—peripheral nervous system neoplasm	0.00112	0.00152	CcSEcCtD
Cyproheptadine—Drowsiness—Epirubicin—peripheral nervous system neoplasm	0.00111	0.00151	CcSEcCtD
Cyproheptadine—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.00111	0.00151	CcSEcCtD
Cyproheptadine—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.00111	0.0015	CcSEcCtD
Cyproheptadine—Rash—Dactinomycin—peripheral nervous system neoplasm	0.0011	0.00149	CcSEcCtD
Cyproheptadine—Decreased appetite—Etoposide—peripheral nervous system neoplasm	0.0011	0.00149	CcSEcCtD
Cyproheptadine—Fatigue—Etoposide—peripheral nervous system neoplasm	0.00109	0.00148	CcSEcCtD
Cyproheptadine—Neuropathy peripheral—Epirubicin—peripheral nervous system neoplasm	0.00109	0.00148	CcSEcCtD
Cyproheptadine—Jaundice—Epirubicin—peripheral nervous system neoplasm	0.00108	0.00147	CcSEcCtD
Cyproheptadine—Constipation—Etoposide—peripheral nervous system neoplasm	0.00108	0.00147	CcSEcCtD
Cyproheptadine—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.00107	0.00145	CcSEcCtD
Cyproheptadine—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.00107	0.00145	CcSEcCtD
Cyproheptadine—Pollakiuria—Doxorubicin—peripheral nervous system neoplasm	0.00107	0.00144	CcSEcCtD
Cyproheptadine—Photosensitivity reaction—Doxorubicin—peripheral nervous system neoplasm	0.00105	0.00143	CcSEcCtD
Cyproheptadine—Weight increased—Doxorubicin—peripheral nervous system neoplasm	0.00105	0.00142	CcSEcCtD
Cyproheptadine—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	0.00104	0.00141	CcSEcCtD
Cyproheptadine—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.00104	0.00141	CcSEcCtD
Cyproheptadine—Agranulocytosis—Epirubicin—peripheral nervous system neoplasm	0.00104	0.00141	CcSEcCtD
Cyproheptadine—Dizziness—Vincristine—peripheral nervous system neoplasm	0.00103	0.0014	CcSEcCtD
Cyproheptadine—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.00103	0.0014	CcSEcCtD
Cyproheptadine—Drowsiness—Doxorubicin—peripheral nervous system neoplasm	0.00103	0.00139	CcSEcCtD
Cyproheptadine—Rash—Alitretinoin—peripheral nervous system neoplasm	0.00102	0.00139	CcSEcCtD
Cyproheptadine—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.00102	0.00138	CcSEcCtD
Cyproheptadine—Headache—Alitretinoin—peripheral nervous system neoplasm	0.00101	0.00138	CcSEcCtD
Cyproheptadine—Neuropathy peripheral—Doxorubicin—peripheral nervous system neoplasm	0.00101	0.00137	CcSEcCtD
Cyproheptadine—Urticaria—Etoposide—peripheral nervous system neoplasm	0.001	0.00136	CcSEcCtD
Cyproheptadine—Jaundice—Doxorubicin—peripheral nervous system neoplasm	0.001	0.00136	CcSEcCtD
Cyproheptadine—Hepatitis—Epirubicin—peripheral nervous system neoplasm	0.000997	0.00135	CcSEcCtD
Cyproheptadine—Vomiting—Vincristine—peripheral nervous system neoplasm	0.000992	0.00135	CcSEcCtD
Cyproheptadine—Carbamazepine—ABCB1—peripheral nervous system neoplasm	0.00099	0.0666	CrCbGaD
Cyproheptadine—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.00099	0.00134	CcSEcCtD
Cyproheptadine—Rash—Vincristine—peripheral nervous system neoplasm	0.000984	0.00133	CcSEcCtD
Cyproheptadine—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.000983	0.00133	CcSEcCtD
Cyproheptadine—Headache—Vincristine—peripheral nervous system neoplasm	0.000978	0.00133	CcSEcCtD
Cyproheptadine—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.000962	0.0013	CcSEcCtD
Cyproheptadine—Agranulocytosis—Doxorubicin—peripheral nervous system neoplasm	0.000959	0.0013	CcSEcCtD
Cyproheptadine—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.000944	0.00128	CcSEcCtD
Cyproheptadine—Tinnitus—Epirubicin—peripheral nervous system neoplasm	0.00093	0.00126	CcSEcCtD
Cyproheptadine—Nausea—Vincristine—peripheral nervous system neoplasm	0.000927	0.00126	CcSEcCtD
Cyproheptadine—Hepatitis—Doxorubicin—peripheral nervous system neoplasm	0.000923	0.00125	CcSEcCtD
Cyproheptadine—Asthenia—Etoposide—peripheral nervous system neoplasm	0.000907	0.00123	CcSEcCtD
Cyproheptadine—Chills—Epirubicin—peripheral nervous system neoplasm	0.000895	0.00121	CcSEcCtD
Cyproheptadine—HTR2A—cerebellum—peripheral nervous system neoplasm	0.000886	0.00561	CbGeAlD
Cyproheptadine—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.000877	0.00119	CcSEcCtD
Cyproheptadine—Rash—Cisplatin—peripheral nervous system neoplasm	0.00087	0.00118	CcSEcCtD
Cyproheptadine—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.000869	0.00118	CcSEcCtD
Cyproheptadine—Diarrhoea—Etoposide—peripheral nervous system neoplasm	0.000865	0.00117	CcSEcCtD
Cyproheptadine—Tinnitus—Doxorubicin—peripheral nervous system neoplasm	0.00086	0.00117	CcSEcCtD
Cyproheptadine—Tension—Epirubicin—peripheral nervous system neoplasm	0.000852	0.00116	CcSEcCtD
Cyproheptadine—Nervousness—Epirubicin—peripheral nervous system neoplasm	0.000843	0.00114	CcSEcCtD
Cyproheptadine—Dizziness—Etoposide—peripheral nervous system neoplasm	0.000836	0.00113	CcSEcCtD
Cyproheptadine—Chills—Doxorubicin—peripheral nervous system neoplasm	0.000828	0.00112	CcSEcCtD
Cyproheptadine—Nausea—Cisplatin—peripheral nervous system neoplasm	0.00082	0.00111	CcSEcCtD
Cyproheptadine—Vision blurred—Epirubicin—peripheral nervous system neoplasm	0.000818	0.00111	CcSEcCtD
Cyproheptadine—Vomiting—Etoposide—peripheral nervous system neoplasm	0.000804	0.00109	CcSEcCtD
Cyproheptadine—Agitation—Epirubicin—peripheral nervous system neoplasm	0.000798	0.00108	CcSEcCtD
Cyproheptadine—Rash—Etoposide—peripheral nervous system neoplasm	0.000797	0.00108	CcSEcCtD
Cyproheptadine—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.000796	0.00108	CcSEcCtD
Cyproheptadine—Headache—Etoposide—peripheral nervous system neoplasm	0.000792	0.00107	CcSEcCtD
Cyproheptadine—Tension—Doxorubicin—peripheral nervous system neoplasm	0.000788	0.00107	CcSEcCtD
Cyproheptadine—Nervousness—Doxorubicin—peripheral nervous system neoplasm	0.00078	0.00106	CcSEcCtD
Cyproheptadine—Vertigo—Epirubicin—peripheral nervous system neoplasm	0.00078	0.00106	CcSEcCtD
Cyproheptadine—Syncope—Epirubicin—peripheral nervous system neoplasm	0.000779	0.00106	CcSEcCtD
Cyproheptadine—Leukopenia—Epirubicin—peripheral nervous system neoplasm	0.000777	0.00105	CcSEcCtD
Cyproheptadine—Palpitations—Epirubicin—peripheral nervous system neoplasm	0.000767	0.00104	CcSEcCtD
Cyproheptadine—Loss of consciousness—Epirubicin—peripheral nervous system neoplasm	0.000763	0.00104	CcSEcCtD
Cyproheptadine—Vision blurred—Doxorubicin—peripheral nervous system neoplasm	0.000757	0.00103	CcSEcCtD
Cyproheptadine—Convulsion—Epirubicin—peripheral nervous system neoplasm	0.000752	0.00102	CcSEcCtD
Cyproheptadine—Nausea—Etoposide—peripheral nervous system neoplasm	0.000751	0.00102	CcSEcCtD
Cyproheptadine—Agitation—Doxorubicin—peripheral nervous system neoplasm	0.000738	0.001	CcSEcCtD
Cyproheptadine—Vertigo—Doxorubicin—peripheral nervous system neoplasm	0.000722	0.000979	CcSEcCtD
Cyproheptadine—Syncope—Doxorubicin—peripheral nervous system neoplasm	0.00072	0.000977	CcSEcCtD
Cyproheptadine—Leukopenia—Doxorubicin—peripheral nervous system neoplasm	0.000719	0.000975	CcSEcCtD
Cyproheptadine—Confusional state—Epirubicin—peripheral nervous system neoplasm	0.000714	0.000969	CcSEcCtD
Cyproheptadine—Palpitations—Doxorubicin—peripheral nervous system neoplasm	0.00071	0.000963	CcSEcCtD
Cyproheptadine—Oedema—Epirubicin—peripheral nervous system neoplasm	0.000709	0.000961	CcSEcCtD
Cyproheptadine—Loss of consciousness—Doxorubicin—peripheral nervous system neoplasm	0.000706	0.000958	CcSEcCtD
Cyproheptadine—Shock—Epirubicin—peripheral nervous system neoplasm	0.000697	0.000946	CcSEcCtD
Cyproheptadine—Convulsion—Doxorubicin—peripheral nervous system neoplasm	0.000696	0.000944	CcSEcCtD
Cyproheptadine—Thrombocytopenia—Epirubicin—peripheral nervous system neoplasm	0.000694	0.000941	CcSEcCtD
Cyproheptadine—Tachycardia—Epirubicin—peripheral nervous system neoplasm	0.000692	0.000938	CcSEcCtD
Cyproheptadine—Hyperhidrosis—Epirubicin—peripheral nervous system neoplasm	0.000685	0.000929	CcSEcCtD
Cyproheptadine—Anorexia—Epirubicin—peripheral nervous system neoplasm	0.000675	0.000916	CcSEcCtD
Cyproheptadine—Hypotension—Epirubicin—peripheral nervous system neoplasm	0.000662	0.000898	CcSEcCtD
Cyproheptadine—Confusional state—Doxorubicin—peripheral nervous system neoplasm	0.000661	0.000897	CcSEcCtD
Cyproheptadine—Oedema—Doxorubicin—peripheral nervous system neoplasm	0.000656	0.000889	CcSEcCtD
Cyproheptadine—Shock—Doxorubicin—peripheral nervous system neoplasm	0.000645	0.000875	CcSEcCtD
Cyproheptadine—Thrombocytopenia—Doxorubicin—peripheral nervous system neoplasm	0.000642	0.000871	CcSEcCtD
Cyproheptadine—Insomnia—Epirubicin—peripheral nervous system neoplasm	0.000641	0.000869	CcSEcCtD
Cyproheptadine—Tachycardia—Doxorubicin—peripheral nervous system neoplasm	0.00064	0.000868	CcSEcCtD
Cyproheptadine—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	0.000636	0.000863	CcSEcCtD
Cyproheptadine—Hyperhidrosis—Doxorubicin—peripheral nervous system neoplasm	0.000634	0.00086	CcSEcCtD
Cyproheptadine—Somnolence—Epirubicin—peripheral nervous system neoplasm	0.00063	0.000855	CcSEcCtD
Cyproheptadine—Anorexia—Doxorubicin—peripheral nervous system neoplasm	0.000625	0.000848	CcSEcCtD
Cyproheptadine—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	0.000624	0.000846	CcSEcCtD
Cyproheptadine—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	0.000616	0.000836	CcSEcCtD
Cyproheptadine—Hypotension—Doxorubicin—peripheral nervous system neoplasm	0.000613	0.000831	CcSEcCtD
Cyproheptadine—Fatigue—Epirubicin—peripheral nervous system neoplasm	0.000611	0.000829	CcSEcCtD
Cyproheptadine—Clozapine—ABCB1—peripheral nervous system neoplasm	0.000609	0.0409	CrCbGaD
Cyproheptadine—Constipation—Epirubicin—peripheral nervous system neoplasm	0.000606	0.000822	CcSEcCtD
Cyproheptadine—Insomnia—Doxorubicin—peripheral nervous system neoplasm	0.000593	0.000804	CcSEcCtD
Cyproheptadine—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	0.000589	0.000799	CcSEcCtD
Cyproheptadine—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	0.000584	0.000792	CcSEcCtD
Cyproheptadine—Somnolence—Doxorubicin—peripheral nervous system neoplasm	0.000583	0.000791	CcSEcCtD
Cyproheptadine—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	0.000577	0.000783	CcSEcCtD
Cyproheptadine—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	0.00057	0.000773	CcSEcCtD
Cyproheptadine—Amitriptyline—ABCB1—peripheral nervous system neoplasm	0.000566	0.0381	CrCbGaD
Cyproheptadine—Fatigue—Doxorubicin—peripheral nervous system neoplasm	0.000565	0.000767	CcSEcCtD
Cyproheptadine—Urticaria—Epirubicin—peripheral nervous system neoplasm	0.000563	0.000764	CcSEcCtD
Cyproheptadine—Constipation—Doxorubicin—peripheral nervous system neoplasm	0.000561	0.000761	CcSEcCtD
Cyproheptadine—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	0.00054	0.000733	CcSEcCtD
Cyproheptadine—Urticaria—Doxorubicin—peripheral nervous system neoplasm	0.000521	0.000707	CcSEcCtD
Cyproheptadine—Asthenia—Epirubicin—peripheral nervous system neoplasm	0.000508	0.00069	CcSEcCtD
Cyproheptadine—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	0.000485	0.000658	CcSEcCtD
Cyproheptadine—Asthenia—Doxorubicin—peripheral nervous system neoplasm	0.00047	0.000638	CcSEcCtD
Cyproheptadine—Dizziness—Epirubicin—peripheral nervous system neoplasm	0.000469	0.000636	CcSEcCtD
Cyproheptadine—Vomiting—Epirubicin—peripheral nervous system neoplasm	0.000451	0.000611	CcSEcCtD
Cyproheptadine—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	0.000449	0.000609	CcSEcCtD
Cyproheptadine—Rash—Epirubicin—peripheral nervous system neoplasm	0.000447	0.000606	CcSEcCtD
Cyproheptadine—Dermatitis—Epirubicin—peripheral nervous system neoplasm	0.000446	0.000606	CcSEcCtD
Cyproheptadine—Headache—Epirubicin—peripheral nervous system neoplasm	0.000444	0.000602	CcSEcCtD
Cyproheptadine—Dizziness—Doxorubicin—peripheral nervous system neoplasm	0.000434	0.000588	CcSEcCtD
Cyproheptadine—Nausea—Epirubicin—peripheral nervous system neoplasm	0.000421	0.000571	CcSEcCtD
Cyproheptadine—Vomiting—Doxorubicin—peripheral nervous system neoplasm	0.000417	0.000565	CcSEcCtD
Cyproheptadine—Rash—Doxorubicin—peripheral nervous system neoplasm	0.000413	0.000561	CcSEcCtD
Cyproheptadine—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	0.000413	0.00056	CcSEcCtD
Cyproheptadine—Headache—Doxorubicin—peripheral nervous system neoplasm	0.000411	0.000557	CcSEcCtD
Cyproheptadine—Nausea—Doxorubicin—peripheral nervous system neoplasm	0.000389	0.000528	CcSEcCtD
Cyproheptadine—HRH1—Signaling Pathways—NTS—peripheral nervous system neoplasm	8.91e-05	0.000987	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—NTS—peripheral nervous system neoplasm	8.88e-05	0.000984	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—NTS—peripheral nervous system neoplasm	8.85e-05	0.000981	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—NTS—peripheral nervous system neoplasm	8.76e-05	0.000971	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—CD55—peripheral nervous system neoplasm	8.7e-05	0.000964	CbGpPWpGaD
Cyproheptadine—HTR1A—GPCR downstream signaling—KNG1—peripheral nervous system neoplasm	8.65e-05	0.000959	CbGpPWpGaD
Cyproheptadine—HTR2C—GPCR downstream signaling—KNG1—peripheral nervous system neoplasm	8.61e-05	0.000954	CbGpPWpGaD
Cyproheptadine—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—peripheral nervous system neoplasm	8.57e-05	0.00095	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—CD55—peripheral nervous system neoplasm	8.56e-05	0.000949	CbGpPWpGaD
Cyproheptadine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—peripheral nervous system neoplasm	8.55e-05	0.000948	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—CD55—peripheral nervous system neoplasm	8.54e-05	0.000947	CbGpPWpGaD
Cyproheptadine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—peripheral nervous system neoplasm	8.53e-05	0.000945	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—CD55—peripheral nervous system neoplasm	8.51e-05	0.000943	CbGpPWpGaD
Cyproheptadine—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—peripheral nervous system neoplasm	8.5e-05	0.000942	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—CD55—peripheral nervous system neoplasm	8.48e-05	0.00094	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	8.47e-05	0.000939	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—CD55—peripheral nervous system neoplasm	8.4e-05	0.000931	CbGpPWpGaD
Cyproheptadine—UGT1A3—Metabolism—GNAS—peripheral nervous system neoplasm	8.32e-05	0.000923	CbGpPWpGaD
Cyproheptadine—UGT1A3—Metabolism—ABCB1—peripheral nervous system neoplasm	8.17e-05	0.000905	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling by GPCR—KNG1—peripheral nervous system neoplasm	7.86e-05	0.000871	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—VIP—peripheral nervous system neoplasm	7.83e-05	0.000868	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling by GPCR—KNG1—peripheral nervous system neoplasm	7.82e-05	0.000867	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—VIP—peripheral nervous system neoplasm	7.79e-05	0.000863	CbGpPWpGaD
Cyproheptadine—DRD2—GPCR downstream signaling—KNG1—peripheral nervous system neoplasm	7.6e-05	0.000842	CbGpPWpGaD
Cyproheptadine—HTR1A—GPCR downstream signaling—GNAS—peripheral nervous system neoplasm	7.57e-05	0.000839	CbGpPWpGaD
Cyproheptadine—HTR2C—GPCR downstream signaling—GNAS—peripheral nervous system neoplasm	7.53e-05	0.000835	CbGpPWpGaD
Cyproheptadine—HTR2A—GPCR downstream signaling—KNG1—peripheral nervous system neoplasm	7.48e-05	0.000829	CbGpPWpGaD
Cyproheptadine—HRH1—GPCR downstream signaling—KNG1—peripheral nervous system neoplasm	7.46e-05	0.000827	CbGpPWpGaD
Cyproheptadine—CHRM1—GPCR downstream signaling—KNG1—peripheral nervous system neoplasm	7.44e-05	0.000824	CbGpPWpGaD
Cyproheptadine—CHRM3—GPCR downstream signaling—KNG1—peripheral nervous system neoplasm	7.41e-05	0.000822	CbGpPWpGaD
Cyproheptadine—CHRM2—GPCR downstream signaling—KNG1—peripheral nervous system neoplasm	7.34e-05	0.000814	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	7.33e-05	0.000813	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	7.23e-05	0.000801	CbGpPWpGaD
Cyproheptadine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—peripheral nervous system neoplasm	7.22e-05	0.000801	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	7.19e-05	0.000797	CbGpPWpGaD
Cyproheptadine—DRD2—Circadian rythm related genes—TP53—peripheral nervous system neoplasm	7.03e-05	0.00078	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling by GPCR—KNG1—peripheral nervous system neoplasm	6.9e-05	0.000765	CbGpPWpGaD
Cyproheptadine—CHRM1—Circadian rythm related genes—TP53—peripheral nervous system neoplasm	6.88e-05	0.000763	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—VIP—peripheral nervous system neoplasm	6.87e-05	0.000762	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	6.87e-05	0.000762	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	6.84e-05	0.000758	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling by GPCR—KNG1—peripheral nervous system neoplasm	6.79e-05	0.000753	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling by GPCR—KNG1—peripheral nervous system neoplasm	6.77e-05	0.000751	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—VIP—peripheral nervous system neoplasm	6.76e-05	0.00075	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling by GPCR—KNG1—peripheral nervous system neoplasm	6.75e-05	0.000749	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—VIP—peripheral nervous system neoplasm	6.75e-05	0.000748	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling by GPCR—KNG1—peripheral nervous system neoplasm	6.73e-05	0.000746	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—VIP—peripheral nervous system neoplasm	6.73e-05	0.000746	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—VIP—peripheral nervous system neoplasm	6.71e-05	0.000743	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	6.69e-05	0.000742	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling by GPCR—KNG1—peripheral nervous system neoplasm	6.67e-05	0.000739	CbGpPWpGaD
Cyproheptadine—DRD2—GPCR downstream signaling—GNAS—peripheral nervous system neoplasm	6.64e-05	0.000737	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—VIP—peripheral nervous system neoplasm	6.64e-05	0.000736	CbGpPWpGaD
Cyproheptadine—HTR2A—GPCR downstream signaling—GNAS—peripheral nervous system neoplasm	6.54e-05	0.000725	CbGpPWpGaD
Cyproheptadine—HRH1—GPCR downstream signaling—GNAS—peripheral nervous system neoplasm	6.52e-05	0.000723	CbGpPWpGaD
Cyproheptadine—CHRM1—GPCR downstream signaling—GNAS—peripheral nervous system neoplasm	6.5e-05	0.000721	CbGpPWpGaD
Cyproheptadine—CHRM3—GPCR downstream signaling—GNAS—peripheral nervous system neoplasm	6.48e-05	0.000719	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	6.45e-05	0.000715	CbGpPWpGaD
Cyproheptadine—CHRM2—GPCR downstream signaling—GNAS—peripheral nervous system neoplasm	6.42e-05	0.000712	CbGpPWpGaD
Cyproheptadine—CHRM3—Metabolism—ENO2—peripheral nervous system neoplasm	6.41e-05	0.000711	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	6.34e-05	0.000703	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling Pathways—KNG1—peripheral nervous system neoplasm	6.27e-05	0.000695	CbGpPWpGaD
Cyproheptadine—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—peripheral nervous system neoplasm	6.27e-05	0.000695	CbGpPWpGaD
Cyproheptadine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—peripheral nervous system neoplasm	6.26e-05	0.000694	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	6.24e-05	0.000692	CbGpPWpGaD
Cyproheptadine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—peripheral nervous system neoplasm	6.24e-05	0.000691	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	6.23e-05	0.00069	CbGpPWpGaD
Cyproheptadine—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—peripheral nervous system neoplasm	6.22e-05	0.000689	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	6.21e-05	0.000688	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	6.19e-05	0.000686	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	6.13e-05	0.000679	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	6.03e-05	0.000669	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	5.98e-05	0.000663	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	5.94e-05	0.000658	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	5.92e-05	0.000657	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	5.9e-05	0.000655	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	5.89e-05	0.000653	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	5.89e-05	0.000652	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	5.83e-05	0.000646	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—KNG1—peripheral nervous system neoplasm	5.72e-05	0.000635	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling Pathways—GNAS—peripheral nervous system neoplasm	5.48e-05	0.000608	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	5.46e-05	0.000605	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	5.43e-05	0.000602	CbGpPWpGaD
Cyproheptadine—CHRM3—Metabolism—BCHE—peripheral nervous system neoplasm	5.42e-05	0.000601	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	5.4e-05	0.000599	CbGpPWpGaD
Cyproheptadine—CHRM3—Metabolism—SLC2A1—peripheral nervous system neoplasm	5.17e-05	0.000573	CbGpPWpGaD
Cyproheptadine—CHRM3—Metabolism—TH—peripheral nervous system neoplasm	5.09e-05	0.000565	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—GNAS—peripheral nervous system neoplasm	5.01e-05	0.000555	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	4.78e-05	0.000529	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	4.76e-05	0.000528	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	4.75e-05	0.000527	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	4.69e-05	0.00052	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	4.68e-05	0.000519	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	4.66e-05	0.000517	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	4.65e-05	0.000515	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—KNG1—peripheral nervous system neoplasm	4.64e-05	0.000515	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—KNG1—peripheral nervous system neoplasm	4.62e-05	0.000512	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	4.6e-05	0.00051	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	4.42e-05	0.00049	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	4.4e-05	0.000488	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	4.19e-05	0.000465	CbGpPWpGaD
Cyproheptadine—CHRM3—Metabolism—GNAS—peripheral nervous system neoplasm	4.16e-05	0.000461	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	4.13e-05	0.000457	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	4.12e-05	0.000456	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	4.1e-05	0.000455	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	4.09e-05	0.000453	CbGpPWpGaD
Cyproheptadine—CHRM3—Metabolism—ABCB1—peripheral nervous system neoplasm	4.08e-05	0.000452	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—KNG1—peripheral nervous system neoplasm	4.08e-05	0.000452	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—GNAS—peripheral nervous system neoplasm	4.06e-05	0.00045	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	4.05e-05	0.000449	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—GNAS—peripheral nervous system neoplasm	4.04e-05	0.000448	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—KNG1—peripheral nervous system neoplasm	4.01e-05	0.000445	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—KNG1—peripheral nervous system neoplasm	4e-05	0.000444	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—KNG1—peripheral nervous system neoplasm	3.99e-05	0.000442	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—KNG1—peripheral nervous system neoplasm	3.98e-05	0.000441	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—KNG1—peripheral nervous system neoplasm	3.94e-05	0.000436	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	3.88e-05	0.000431	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	3.88e-05	0.00043	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	3.82e-05	0.000424	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	3.81e-05	0.000423	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	3.81e-05	0.000422	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	3.8e-05	0.000421	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	3.79e-05	0.00042	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	3.75e-05	0.000416	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—GNAS—peripheral nervous system neoplasm	3.56e-05	0.000395	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	3.54e-05	0.000393	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—GNAS—peripheral nervous system neoplasm	3.51e-05	0.000389	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—GNAS—peripheral nervous system neoplasm	3.5e-05	0.000388	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—GNAS—peripheral nervous system neoplasm	3.49e-05	0.000387	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	3.48e-05	0.000386	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—GNAS—peripheral nervous system neoplasm	3.48e-05	0.000385	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—GNAS—peripheral nervous system neoplasm	3.44e-05	0.000382	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	3.01e-05	0.000334	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	2.87e-05	0.000318	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	2.86e-05	0.000317	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	2.84e-05	0.000315	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	2.82e-05	0.000313	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	2.81e-05	0.000311	CbGpPWpGaD
Cyproheptadine—HTR6—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	2.76e-05	0.000306	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	2.75e-05	0.000305	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling Pathways—CASP3—peripheral nervous system neoplasm	2.73e-05	0.000303	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	2.59e-05	0.000287	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	2.52e-05	0.000279	CbGpPWpGaD
Cyproheptadine—HTR2B—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	2.52e-05	0.000279	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	2.51e-05	0.000278	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—CASP3—peripheral nervous system neoplasm	2.5e-05	0.000277	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	2.48e-05	0.000275	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	2.48e-05	0.000275	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	2.48e-05	0.000274	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	2.47e-05	0.000274	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	2.46e-05	0.000273	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	2.44e-05	0.00027	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	2.44e-05	0.00027	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	2.43e-05	0.00027	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	2.42e-05	0.000269	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	2.42e-05	0.000268	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	2.39e-05	0.000265	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling Pathways—NRAS—peripheral nervous system neoplasm	2.29e-05	0.000254	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	2.29e-05	0.000254	CbGpPWpGaD
Cyproheptadine—UGT1A3—Metabolism—AKT1—peripheral nervous system neoplasm	2.25e-05	0.000249	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	2.23e-05	0.000247	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	2.22e-05	0.000246	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling Pathways—MYC—peripheral nervous system neoplasm	2.13e-05	0.000237	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	2.1e-05	0.000233	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—NRAS—peripheral nervous system neoplasm	2.09e-05	0.000232	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	2.09e-05	0.000232	CbGpPWpGaD
Cyproheptadine—HTR1A—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	2.04e-05	0.000226	CbGpPWpGaD
Cyproheptadine—HTR2C—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	2.03e-05	0.000225	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—CASP3—peripheral nervous system neoplasm	2.02e-05	0.000224	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—CASP3—peripheral nervous system neoplasm	2.01e-05	0.000223	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	1.96e-05	0.000217	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—MYC—peripheral nervous system neoplasm	1.95e-05	0.000216	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	1.93e-05	0.000214	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	1.92e-05	0.000213	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	1.92e-05	0.000212	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	1.91e-05	0.000212	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	1.89e-05	0.00021	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	1.85e-05	0.000206	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	1.85e-05	0.000205	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	1.84e-05	0.000204	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	1.81e-05	0.000201	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	1.81e-05	0.000201	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	1.8e-05	0.0002	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	1.8e-05	0.000199	CbGpPWpGaD
Cyproheptadine—DRD2—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	1.79e-05	0.000199	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	1.78e-05	0.000198	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—CASP3—peripheral nervous system neoplasm	1.78e-05	0.000197	CbGpPWpGaD
Cyproheptadine—HTR2A—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	1.76e-05	0.000196	CbGpPWpGaD
Cyproheptadine—HRH1—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	1.76e-05	0.000195	CbGpPWpGaD
Cyproheptadine—CHRM1—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	1.75e-05	0.000195	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling Pathways—TP53—peripheral nervous system neoplasm	1.75e-05	0.000194	CbGpPWpGaD
Cyproheptadine—CHRM3—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	1.75e-05	0.000194	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—CASP3—peripheral nervous system neoplasm	1.75e-05	0.000194	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—CASP3—peripheral nervous system neoplasm	1.74e-05	0.000193	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—CASP3—peripheral nervous system neoplasm	1.74e-05	0.000193	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—CASP3—peripheral nervous system neoplasm	1.73e-05	0.000192	CbGpPWpGaD
Cyproheptadine—CHRM2—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	1.73e-05	0.000192	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—CASP3—peripheral nervous system neoplasm	1.72e-05	0.00019	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—NRAS—peripheral nervous system neoplasm	1.7e-05	0.000188	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—NRAS—peripheral nervous system neoplasm	1.69e-05	0.000187	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling Pathways—HRAS—peripheral nervous system neoplasm	1.68e-05	0.000186	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	1.63e-05	0.000181	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	1.6e-05	0.000178	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—TP53—peripheral nervous system neoplasm	1.6e-05	0.000177	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	1.6e-05	0.000177	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	1.59e-05	0.000177	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	1.59e-05	0.000176	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—MYC—peripheral nervous system neoplasm	1.58e-05	0.000175	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	1.57e-05	0.000174	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—MYC—peripheral nervous system neoplasm	1.57e-05	0.000174	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—HRAS—peripheral nervous system neoplasm	1.53e-05	0.00017	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—NRAS—peripheral nervous system neoplasm	1.49e-05	0.000165	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling Pathways—AKT1—peripheral nervous system neoplasm	1.48e-05	0.000164	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—NRAS—peripheral nervous system neoplasm	1.47e-05	0.000162	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—NRAS—peripheral nervous system neoplasm	1.46e-05	0.000162	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—NRAS—peripheral nervous system neoplasm	1.46e-05	0.000162	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—NRAS—peripheral nervous system neoplasm	1.45e-05	0.000161	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—NRAS—peripheral nervous system neoplasm	1.44e-05	0.000159	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—MYC—peripheral nervous system neoplasm	1.39e-05	0.000154	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—MYC—peripheral nervous system neoplasm	1.36e-05	0.000151	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—MYC—peripheral nervous system neoplasm	1.36e-05	0.000151	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—MYC—peripheral nervous system neoplasm	1.36e-05	0.00015	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—MYC—peripheral nervous system neoplasm	1.35e-05	0.00015	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—AKT1—peripheral nervous system neoplasm	1.35e-05	0.00015	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—MYC—peripheral nervous system neoplasm	1.34e-05	0.000149	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—TP53—peripheral nervous system neoplasm	1.3e-05	0.000144	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—TP53—peripheral nervous system neoplasm	1.29e-05	0.000143	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—HRAS—peripheral nervous system neoplasm	1.24e-05	0.000138	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—HRAS—peripheral nervous system neoplasm	1.23e-05	0.000137	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—TP53—peripheral nervous system neoplasm	1.14e-05	0.000126	CbGpPWpGaD
Cyproheptadine—CHRM3—Metabolism—AKT1—peripheral nervous system neoplasm	1.12e-05	0.000124	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—TP53—peripheral nervous system neoplasm	1.12e-05	0.000124	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—TP53—peripheral nervous system neoplasm	1.12e-05	0.000124	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—TP53—peripheral nervous system neoplasm	1.11e-05	0.000124	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—TP53—peripheral nervous system neoplasm	1.11e-05	0.000123	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—TP53—peripheral nervous system neoplasm	1.1e-05	0.000122	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—AKT1—peripheral nervous system neoplasm	1.1e-05	0.000121	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—AKT1—peripheral nervous system neoplasm	1.09e-05	0.000121	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—HRAS—peripheral nervous system neoplasm	1.09e-05	0.000121	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—HRAS—peripheral nervous system neoplasm	1.07e-05	0.000119	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—HRAS—peripheral nervous system neoplasm	1.07e-05	0.000119	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—HRAS—peripheral nervous system neoplasm	1.07e-05	0.000118	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—HRAS—peripheral nervous system neoplasm	1.06e-05	0.000118	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—HRAS—peripheral nervous system neoplasm	1.05e-05	0.000117	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—AKT1—peripheral nervous system neoplasm	9.62e-06	0.000107	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—AKT1—peripheral nervous system neoplasm	9.47e-06	0.000105	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—AKT1—peripheral nervous system neoplasm	9.44e-06	0.000105	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—AKT1—peripheral nervous system neoplasm	9.41e-06	0.000104	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—AKT1—peripheral nervous system neoplasm	9.38e-06	0.000104	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—AKT1—peripheral nervous system neoplasm	9.29e-06	0.000103	CbGpPWpGaD
